摘要
目的 探讨对神经内科头痛患者采用头痛宁胶囊进行治疗后获得临床效果。方法 选取2018年1月~2020年12月山东国欣颐养集团枣庄中心医院收治的40例神经内科头痛患者,随机分为参照组(采用常规疗法完成头痛治疗)和试验组(采用常规疗法+头痛宁胶囊完成头痛治疗),每组各20例;比较两组患者的疗效。结果 试验组治疗总有效率(90.00%)明显高于参照组(55.00%)(P<0.05);参照组不良反应(胃肠道反应、头晕、皮肤瘙痒)发生率为20.00%,试验组为15.00%,差异无统计学意义(P>0.05);试验组疾病发作次数(2.05±0.39)次/d、持续时间(19.99±3.65)min/次,均低于参照组疾病的(3.95±0.55)次/d、(26.69±4.65)min/次,差异有统计学意义(P<0.05);治疗前,试验组疼痛程度评分(7.13±1.25)分及HIT评分(66.11±1.69)分,与参照组疼痛程度评分(7.15±1.27)分及HIT评分(66.18±1.72)分比较,差异无统计学意义(P>0.05);治疗后,试验组疼痛程度评分(1.13±0.29)分及HIT评分(40.49±2.12)分均低于参照组的(3.49±0.31)分及(59.49±3.99)分,差异有统计学意义(P<0.05)。结论 头痛宁胶囊有效应用后,可显著提高患者临床疗效,减少疾病发作次数并且缩短持续时间、改善疼痛程度,最终促进神经内科头痛患者综合治疗效果、预后水平双重提升。
Objective To explore the clinical effect of Toutongning capsules in the treatment of headache patients in neurology department. Methods A total of 40 headache patients admitted to the neurology department from January2018 to December 2020 were selected for treatment research.They were randomly divided into the reference group(headache treated by conventional therapy) and the experimental group(headache treated by conventional therapy +Toutouning capsules), with 20 cases in each group.The treatment results of the two groups were compared. Results The total effective rate of the experimental group(90.00%) was higher than that of the reference group(55.00%),with statistically significant differences(P<0.05). There was no statistically significant difference in the total incidence of adverse reactions(gastrointestinal reactions, dizziness and skin pruritus) between the experimental group(15.00%) and the reference group(20.00%,P>0.05).The number and duration of disease onsets in the experimental group [(2.05±0.39)times/d,(19.99 ±3.65)min/onset] were lower than those in the reference group[(3.95±0.55) times/d,(26.69±4.65)min/onset], with statistically significant differences(P<0.05). Before treatment, there were no statistically significant differences in the pain score andHeadache Impact Test(HIT) score between the experimental group[(7.13 ±1.25) points and(66.11±1.69)points] and the reference group [(7.15 ±1.27) points and(66.18±1.72) points,P>0.05]. After treatment, the pain score and HIT score[(1.13±0.29)points and(40.49±2.12)points] of the experimental group were lower than those of the reference group [(3.49 ±0.31)points and(59.49 ±3.99)points], with statistically significant differences(P <0.05). Conclusion The effective application of Toutongning capsules can significantly promote the clinical efficacy, reduce the number of disease onsets,shorten the onset duration, improve the degree of pain,and finally advance the comprehensive treatment effect and prognosis of headache patients in neurology department.
作者
张晴
ZHANG Qing(Department of Neuroelectrophysiology,Zaozhuang Central Hospital of Shandong GuoxinHealthcare Group,Zaozhuang 277000,China)
出处
《中国现代医生》
2022年第16期110-112,共3页
China Modern Doctor
关键词
神经内科头痛
头痛宁胶囊
疗效
疾病发作次数
持续时间
疼痛程度
HIT评分
Headache in neurology department
Toutongning capsules
Efficacy
Number of disease onsets
Duration
Degree of pain
HIT score
